Harvard Bioscience, Inc. (HBIO)
- Previous Close
3.7200 - Open
3.7100 - Bid 2.6700 x 200
- Ask 4.7300 x 200
- Day's Range
3.6895 - 3.7500 - 52 Week Range
3.6000 - 6.2900 - Volume
5,976 - Avg. Volume
88,024 - Market Cap (intraday)
161.093M - Beta (5Y Monthly) 1.45
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0800 - Earnings Date Apr 24, 2024 - Apr 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.92
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
www.harvardbioscience.comRecent News: HBIO
Performance Overview: HBIO
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HBIO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HBIO
Valuation Measures
Market Cap
161.53M
Enterprise Value
200.02M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.41
Price/Book (mrq)
2.21
Enterprise Value/Revenue
1.78
Enterprise Value/EBITDA
24.90
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.04%
Return on Assets (ttm)
1.10%
Return on Equity (ttm)
-4.70%
Revenue (ttm)
112.25M
Net Income Avi to Common (ttm)
-3.42M
Diluted EPS (ttm)
-0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
4.28M
Total Debt/Equity (mrq)
58.53%
Levered Free Cash Flow (ttm)
13.11M
Research Analysis: HBIO
Company Insights: HBIO
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: HBIO
Daily – Vickers Top Insider Picks for 11/17/2022
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 11/16/2022
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 11/15/2022
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 11/11/2022
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.